MORGAN STANLEY

Holdings History for Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN)

Symbol: VRDN on Nasdaq
Investment type: Equity / Common Stock, $0.01 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0%	$60	1	0		$60.00 ^*	Q4 2025
31 Dec 2025	0%	+0%	$54,093,536	1,738,224	+1,546,283	+806%	$31.12	Q4 2025
30 Sep 2025	0%	-0%	$4,142,090	191,941	-8,426	-4.2%	$21.58	Q3 2025
30 Jun 2025	0%	-0%	$2,801,135	200,367	-141,428	-41%	$13.98	Q2 2025
31 Mar 2025	0%	-0%	$4,607,398	341,795	-397,344		$13.48	Q1 2025
31 Dec 2024		0%	$33	1	0		$33.00 ^*	Q4 2024
31 Dec 2024	0%	-0%	$14,169,294	739,139	-270,740		$19.17	Q4 2024
30 Sep 2024	0%	+0%	$22,974,749	1,009,879	+689,309	+200%	$22.75	Q3 2024
30 Jun 2024	0%	-0%	$4,170,620	320,570	-241,971		$13.01	Q2 2024
31 Mar 2024	0%	+0%	$9,850,094	562,541	+37,640	+7.2%	$17.51	Q1 2024
31 Dec 2023	0%	+0%	$11,432,344	524,901	+191,178	+57%	$21.78	Q4 2023
30 Sep 2023	0%	+0%	$5,119,313	333,723	+264,044	+379%	$15.34	Q3 2023
30 Jun 2023	0%	-0%	$1,657,665	69,679	-363,455	-84%	$23.79	Q2 2023
31 Mar 2023	0%	+0%	$11,018,928	433,134	+97,832	+29%	$25.44	Q1 2023
31 Dec 2022	0%	+0%	$9,794,172	335,302	+170,579	+104%	$29.21	Q4 2022
30 Sep 2022		0%	$1,000	27	0		$37.04 ^*	Q3 2022
30 Sep 2022	0%	+0%	$3,378,000	164,723	+137,250	+500%	$20.51	Q3 2022
30 Jun 2022		0%	$1,000	110	0		$9.09 ^*	Q2 2022
30 Jun 2022	0%	-0%	$318,000	27,473	-7,456	-21%	$11.58	Q2 2022
31 Mar 2022	0%	+0%	$646,000	34,929	+21,234	+155%	$18.49	Q1 2022
31 Dec 2021	0%	+0%	$271,000	13,695	+3,780	+38%	$19.79	Q4 2021
30 Sep 2021	0%	+0%	$163,000	9,915	+2,930	+42%	$16.44	Q3 2021
30 Jun 2021	0%	+0%	$128,000	6,985	+6,985	NEW	$18.32	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.